Characteristics of pyrexia in BRAF V600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial
Titel:
Characteristics of pyrexia in BRAF V600E/K metastatic melanoma patients treated with combined dabrafenib and trametinib in a phase I/II clinical trial
Auteur:
Menzies, A.M. Ashworth, M.T. Swann, S. Kefford, R.F. Flaherty, K. Weber, J. Infante, J.R. Kim, K.B. Gonzalez, R. Hamid, O. Schuchter, L. Cebon, J. Sosman, J.A. Little, S. Sun, P. Aktan, G. Ouellet, D. Jin, F. Long, G.V. Daud, A.